Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lloyd Holder

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neuron|May 8, 2020
Unwind and Relax: DDX3X RNA Helicase as a Critical Mediator of Cortical NeurogenesisBlake Vuocolo, J Lloyd Holder
Epilepsia|August 25, 2016
The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutationsJ Lloyd Holder, Michael M Quach
Expert Opinion on Pharmacotherapy|October 5, 2011
Zonisamide in the treatment of epilepsyJ Lloyd Holder, Angus A Wilfong
American Journal of Medical Genetics. Part A|July 4, 2015
Refinement of the postnatal growth restriction locus of chromosome 5q12-13 deletion syndromeJ Lloyd Holder, Sau-Wai Cheung
Frontiers in Pediatrics|December 14, 2023
Social behavioral impairments in <i>SYNGAP1</i>-related intellectual disabilityHajer Naveed, Maria McCormack, J Lloyd Holder
Neurology. Genetics|April 29, 2016
Exonic deletion of SLC9A9 in autism with epilepsyMeeta Cardon, Karen D Evankovich, J Lloyd Holder
Journal of Neurodevelopmental Disorders|February 7, 2018
The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulatorsMonica Weldon, Murat Kilinc, J Lloyd Holder, et al.
American Journal of Medical Genetics. Part A|November 21, 2024
Chronic Catatonia in an Individual With a De Novo Missense SHANK1 VariantPaige M Dahlberg, Holly K Harris, J Lloyd Holder
American Journal of Medical Genetics. Part A|April 11, 2012
A child with an inherited 0.31 Mb microdeletion of chromosome 14q32.33: further delineation of a critical region for the 14q32 deletion syndromeJ Lloyd Holder, Timothy E Lotze, Carlos Bacino, et al.
Molecular Endocrinology (Baltimore, Md.)|May 27, 2006
Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neuronsBassil M Kublaoui, J Lloyd Holder, Terry Gemelli, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neuron|May 8, 2020
Unwind and Relax: DDX3X RNA Helicase as a Critical Mediator of Cortical NeurogenesisBlake Vuocolo, J Lloyd Holder
Epilepsia|August 25, 2016
The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutationsJ Lloyd Holder, Michael M Quach
Expert Opinion on Pharmacotherapy|October 5, 2011
Zonisamide in the treatment of epilepsyJ Lloyd Holder, Angus A Wilfong
American Journal of Medical Genetics. Part A|July 4, 2015
Refinement of the postnatal growth restriction locus of chromosome 5q12-13 deletion syndromeJ Lloyd Holder, Sau-Wai Cheung
Frontiers in Pediatrics|December 14, 2023
Social behavioral impairments in <i>SYNGAP1</i>-related intellectual disabilityHajer Naveed, Maria McCormack, J Lloyd Holder
Neurology. Genetics|April 29, 2016
Exonic deletion of SLC9A9 in autism with epilepsyMeeta Cardon, Karen D Evankovich, J Lloyd Holder
Journal of Neurodevelopmental Disorders|February 7, 2018
The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulatorsMonica Weldon, Murat Kilinc, J Lloyd Holder, et al.
American Journal of Medical Genetics. Part A|November 21, 2024
Chronic Catatonia in an Individual With a De Novo Missense SHANK1 VariantPaige M Dahlberg, Holly K Harris, J Lloyd Holder
American Journal of Medical Genetics. Part A|April 11, 2012
A child with an inherited 0.31 Mb microdeletion of chromosome 14q32.33: further delineation of a critical region for the 14q32 deletion syndromeJ Lloyd Holder, Timothy E Lotze, Carlos Bacino, et al.
Molecular Endocrinology (Baltimore, Md.)|May 27, 2006
Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neuronsBassil M Kublaoui, J Lloyd Holder, Terry Gemelli, et al.
Pageof 4